← Back to Patent Explorer
US5371104A Expired / Lapsed US ⏱️ 0.0 years remaining

Compositions containing forskolin

Assignee: Individual
•
Filing: 1994-02-18
•
Granted: 1994-12-06
•
Expires: 2014-02-18
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention relates to a process for the solubilzation of forskolin, to the pharmaceutical compositions based on such solubilized forskolin and to the use of these in the treatment of various diseases and disorders and maladies in mammals, including human. Forskolin is 7-beta-acetoxy-8,13-epoxy-1-alpha,6-beta,9-alpha-trihydroxylabd-14-en-11-one.

Inventors

  • 👤 Jeffery J. Feigenbaum

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 17:12
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/335; A61K31/35

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 40 words
A method for providing analgesia in a mammal, comprising the step of: administering to said mammal a dose of between about 0.001 to about 1.0 mg/kg/day of a composition essentially of forskokin solubilized in dimethyl sulfoxide and a surface-active agent.
Claim 2
Independent Claim 40 words
A method for providing analgesia in a mammal, comprising the step of: administering to said mammal a dose of between about 0.001 to about 1.0 mg/kg/day of a composition essentially of forskokin solubilized in dimethyl sulfoxide and a surface-active agent.
Claim 3
Dependent Claim 27 words
The method of claim 1, wherein said composition is administered in an amount effective to provide a dose of forskolin from about 0.001 to about 0.005 mg/kg/day.
Claim 4
Dependent Claim 21 words
The method of claim 1, wherein said composition is administered at a dose of from about 0.1 to about 1.0 mg/kg/day.

References Cited (Backward Citations)

US4120975A Cited
US4588724A Cited
US4517200A Cited
US4782082A Cited
US4564626A Cited
US4724238A Cited
US4871764A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1997-12-05 1998-06-06 1998-12-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2001-12-05 2002-06-06 2002-12-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2005-12-05 2006-06-06 2006-12-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag